EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Novel potential pharmacological applications of dimethyl fumarate—an overview and update

Giorgia Bresciani, Federico Manai, Sergio Davinelli, Paolo Tucci, Luciano Saso, Marialaura Amadio

Frontiers in Pharmacology · 07.09.2023 · 14

DOI: 10.3389/fphar.2023.1264842 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 07.09.2023. Verfasst von Giorgia Bresciani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pharmacology, Department of Drug Sciences, University of Pavia, Pavia, Italy. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 213 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dimethyl fumarate (DMF) is an FDA-approved drug for the treatment of psoriasis and multiple sclerosis. DMF is known to stabilize the transcription factor Nrf2, which in turn induces the expression of antioxidant response element genes. It has also been shown that DMF influences autophagy and participates in the transcriptional control of inflammatory factors by inhibiting NF-κB and its downstream targets. DMF is receiving increasing attention for its potential to be repurposed for several diseases. This versatile molecule is indeed able to exert beneficial effects on different medical conditions through a pleiotropic mechanism, in virtue of its antioxidant, immunomodulatory, neuroprotective, anti-inflammatory, and anti-proliferative effects. A growing number of preclinical and clinical studies show that DMF may have important therapeutic implications for chronic diseases, such as cardiovascular and respiratory pathologies, cancer, eye disorders, neurodegenerative conditions, and systemic or organ specific inflammatory and immune-mediated diseases. This comprehensive review summarizes and highlights the plethora of DMF’s beneficial effects and underlines its repurposing opportunities in a variety of clinical conditions.

Schlagwörter

Stichwörter der Autor:innen

Nrf2 pathwayantioxidantcardiovasculardimethyl fumaratedrug repurposinginflammationneurodegenerativeoxidative stress

Autor:innen und Institutionen

  • Section of Pharmacology, Department of Drug Sciences, University of Pavia, Pavia, Italy.
  • Department of Biology and Biotechnology L. Spallanzani, University of Pavia, Pavia, Italy.
  • Department of Medicine and Health Sciences "V. Tiberio", University of Molise, Campobasso, Italy.
  • Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
  • Department of Physiology and Pharmacology Vittorio Erspamer, Sapienza University, Rome, Italy.

Zitieren

APA

Bresciani, G., Manai, F., Davinelli, S., Tucci, P., Saso, L., & Amadio, M. (2023). Novel potential pharmacological applications of dimethyl fumarate—an overview and update. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1264842

Vancouver

Bresciani G, Manai F, Davinelli S, Tucci P, Saso L, Amadio M. Novel potential pharmacological applications of dimethyl fumarate—an overview and update. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1264842

BibTeX
@article{Bresciani2023,
  author = {Bresciani, Giorgia and Manai, Federico and Davinelli, Sergio and Tucci, Paolo and Saso, Luciano and Amadio, Marialaura},
  title = {Novel potential pharmacological applications of dimethyl fumarate—an overview and update},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1264842}
}
Kostenlos starten →